Cotargeting BCL-2 and BCL-XL for maximal efficacy in ALL.

Daver, Naval

Cotargeting BCL-2 and BCL-XL for maximal efficacy in ALL. [electronic resource] - Blood 09 2016 - 1316-7 p. digital

Publication Type: Journal Article; Comment

1528-0020

10.1182/blood-2016-07-724948 doi


Apoptosis
Humans
Proto-Oncogene Proteins c-bcl-2
bcl-X Protein